Ketamine Withdrawn Phase 3 Trials for Suicide / Depression Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02418702A Study to Decrease Suicidal Thinking Using Ketamine